Entering text into the input field will update the search result below

PatternDNA Long & Short Update from April 1st

Apr. 08, 2011 10:24 AM ETGNI, EBIX, CCF, SPEC
ZignalsApps profile picture
ZignalsApps's Blog
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Seeking Alpha Analyst Since 2010

ZignalsApps integrates the most advanced capabilities of Zignals trading tools with Seeking Alpha's depth of content to offer convenience and research horse power, all on a single page. ZignalsApps delivers in two forms: [1] Powerful investing applications suited to your individual needs [2] A suite of tools with cross-application support. You decide what's best for you.

The picks we reviewed for last week were drawn from a scan created by Alan Brochstein. The projections drawn from this group of stocks did not augur for big gains. The general neutral outlook underestimated some of the losses for individual stocks with Great Northern Iron (GNI) and Ebix (EBIX) giving up -9.0% or more.

LaBarge saw a buyout which meant the stock jumped +6.7% on the week, although it was the only big gainer. Chase (CCF) and Spectrun Control (OTCPK:SPEC) were the only other higher closers at +2.3% and 0.3% respectively.

PatternDNA had a 67% success rate from a small sample of three strong projections (and all three favoured downside). Given there was no strong upside projections, PatternDNA did its bit to keep out of the market in what amounted to very narrow trading on the week. 

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.